Rane A. Harrison

957 total citations
12 papers, 408 citations indexed

About

Rane A. Harrison is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Rane A. Harrison has authored 12 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Immunology. Recurrent topics in Rane A. Harrison's work include Protein Kinase Regulation and GTPase Signaling (3 papers), Extracellular vesicles in disease (3 papers) and Cancer therapeutics and mechanisms (2 papers). Rane A. Harrison is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (3 papers), Extracellular vesicles in disease (3 papers) and Cancer therapeutics and mechanisms (2 papers). Rane A. Harrison collaborates with scholars based in United States, South Korea and Brazil. Rane A. Harrison's co-authors include John R. Engen, Kenneth D. Westover, John C. Hunter, Martin A. Carrasco, Nathanael S. Gray, Matthew Meyerson, Hwan Geun Choi, Michael E. Pacold, Jarrod A. Marto and Taebo Sim and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Molecular Biology and Cancer Research.

In The Last Decade

Rane A. Harrison

11 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rane A. Harrison United States 6 362 92 46 45 45 12 408
Kari Kopra Finland 12 374 1.0× 55 0.6× 41 0.9× 33 0.7× 42 0.9× 40 438
K.L. Terry United States 4 308 0.9× 74 0.8× 18 0.4× 40 0.9× 67 1.5× 4 353
Domenico Fasci United States 10 460 1.3× 88 1.0× 106 2.3× 54 1.2× 156 3.5× 11 588
Renate Hornberger Germany 5 383 1.1× 86 0.9× 93 2.0× 19 0.4× 107 2.4× 5 474
Anna Koren Austria 10 473 1.3× 178 1.9× 21 0.5× 39 0.9× 19 0.4× 17 583
Henrik Moebitz Switzerland 5 325 0.9× 119 1.3× 13 0.3× 105 2.3× 42 0.9× 8 441
Stephan Krapp Germany 9 345 1.0× 71 0.8× 10 0.2× 86 1.9× 64 1.4× 14 456
Christine Fernandes United States 9 278 0.8× 68 0.7× 12 0.3× 72 1.6× 85 1.9× 9 356
Nattawadee Panyain United Kingdom 8 199 0.5× 35 0.4× 29 0.6× 45 1.0× 46 1.0× 11 254
William F. Waas United States 13 516 1.4× 73 0.8× 10 0.2× 23 0.5× 31 0.7× 15 570

Countries citing papers authored by Rane A. Harrison

Since Specialization
Citations

This map shows the geographic impact of Rane A. Harrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rane A. Harrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rane A. Harrison more than expected).

Fields of papers citing papers by Rane A. Harrison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rane A. Harrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rane A. Harrison. The network helps show where Rane A. Harrison may publish in the future.

Co-authorship network of co-authors of Rane A. Harrison

This figure shows the co-authorship network connecting the top 25 collaborators of Rane A. Harrison. A scholar is included among the top collaborators of Rane A. Harrison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rane A. Harrison. Rane A. Harrison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
McConnell, Russell E., Rane A. Harrison, Su Chul Jang, et al.. (2023). Therapeutic extracellular vesicle production is substantially increased by inhibition of cellular cholesterol biosynthesis. Biotechnology and Bioengineering. 120(9). 2685–2699. 1 indexed citations
2.
3.
4.
Dooley, Kevin, Ke Xu, Sonya Haupt, et al.. (2019). Abstract 2150: engEx: A novel exosome engineering platform enabling targeted transfer of pharmacological molecules. 2150–2150. 2 indexed citations
5.
Lu, Jia, Rane A. Harrison, Lianbo Li, et al.. (2017). KRAS G12C Drug Development: Discrimination between Switch II Pocket Configurations Using Hydrogen/Deuterium-Exchange Mass Spectrometry. Structure. 25(9). 1442–1448.e3. 26 indexed citations
6.
Gu, Chungang, Michelle L. Lamb, Jeffrey W. Johannes, et al.. (2016). Modulating the strength of hydrogen bond acceptors to achieve low Caco2 efflux for oral bioavailability of PARP inhibitors blocking centrosome clustering. Bioorganic & Medicinal Chemistry Letters. 26(19). 4775–4780. 5 indexed citations
7.
Harrison, Rane A. & John R. Engen. (2016). Conformational insight into multi-protein signaling assemblies by hydrogen–deuterium exchange mass spectrometry. Current Opinion in Structural Biology. 41. 187–193. 55 indexed citations
8.
Harrison, Rane A., Jia Lu, Martin A. Carrasco, et al.. (2016). Structural Dynamics in Ras and Related Proteins upon Nucleotide Switching. Journal of Molecular Biology. 428(23). 4723–4735. 27 indexed citations
9.
Lim, Sang Min, Kenneth D. Westover, Scott B. Ficarro, et al.. (2013). Therapeutic Targeting of Oncogenic K‐Ras by a Covalent Catalytic Site Inhibitor. Angewandte Chemie International Edition. 53(1). 199–204. 246 indexed citations
10.
Shapiro, Adam B., et al.. (2013). Improvement of the Pharmacokinetics and In Vivo Antibacterial Efficacy of a Novel Type IIa Topoisomerase Inhibitor by Formulation in Liposomes. Antimicrobial Agents and Chemotherapy. 57(10). 4816–4824. 5 indexed citations
11.
Lim, Sang Min, Kenneth D. Westover, Scott B. Ficarro, et al.. (2013). Therapeutic Targeting of Oncogenic K‐Ras by a Covalent Catalytic Site Inhibitor. Angewandte Chemie. 126(1). 203–208. 28 indexed citations
12.
Saeh, Jamal, Bin Yang, Bo Peng, et al.. (2012). Abstract 2916: Discovery of pyrazolimidazopyridine compounds as potent in vitro and in vivo anaplastic lymphoma kinase inhibitors. Cancer Research. 72(8_Supplement). 2916–2916.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kari Kopra Breakdown of academic impact, for papers by K.L. Terry Breakdown of academic impact, for papers by Domenico Fasci Breakdown of academic impact, for papers by Renate Hornberger Breakdown of academic impact, for papers by Anna Koren Breakdown of academic impact, for papers by Henrik Moebitz Breakdown of academic impact, for papers by Stephan Krapp Breakdown of academic impact, for papers by Christine Fernandes Breakdown of academic impact, for papers by Nattawadee Panyain Breakdown of academic impact, for papers by William F. Waas
Rankless by CCL
2026